Tingyi Xia

Summary

Affiliation: Sun Yat-sen University
Country: China

Publications

  1. ncbi request reprint Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer
    Tingyi Xia
    Department of Radiation Oncology, Air Force General Hospital, Beijing, People s Republic of China
    Int J Radiat Oncol Biol Phys 66:117-25. 2006
  2. doi request reprint [A randomized phase I/II trial to compare weekly usage with triple weekly usage of paclitaxel in concurrent radiochemotherapy for patients with locally advanced non-small cell lung cancer]
    Anhui Shi
    Department of Radiation Oncology, Beijing Cancer Hospital and Institute, Peking University School of Oncology, Beijing, China
    Zhongguo Fei Ai Za Zhi 14:227-32. 2011

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer
    Tingyi Xia
    Department of Radiation Oncology, Air Force General Hospital, Beijing, People s Republic of China
    Int J Radiat Oncol Biol Phys 66:117-25. 2006
    ..To evaluate the efficacy and toxicity of hypofractionated stereotactic body radiotherapy in patients with Stage I/II non-small-cell lung cancer...
  2. doi request reprint [A randomized phase I/II trial to compare weekly usage with triple weekly usage of paclitaxel in concurrent radiochemotherapy for patients with locally advanced non-small cell lung cancer]
    Anhui Shi
    Department of Radiation Oncology, Beijing Cancer Hospital and Institute, Peking University School of Oncology, Beijing, China
    Zhongguo Fei Ai Za Zhi 14:227-32. 2011
    ..The aim of this study is to compare weekly usage with triple weekly usage of paclitaxel in concurrent radiochemotherapy for patients with LANSCLC, and to obtain the best paclitaxel regimen in the concurrent radiochemotherapy...